In this study, we analyzed the size of the HO-1 promoter (GT)n in 1153 human study subjects to assess the possible contribution of genetic variation to liver cancer development in a Taiwanese adult population; a retrospective cohort was established and followed for over 20 years [26]. This evidence concerns the gene HMOX1 and liver cancer.